Develop Diagnostic Suppliers Serving Syria

Inspired by the ingenuity and passion of David Muir, Passy Muir is committed to enhancing quality of life through quality products, and a commitment to excellence in education. Diagnosed with muscular dystrophy, David Muir eventually became ...

With over 20-years’ experience in nucleic acid extraction reagents, GeneAll Biotechnology will work with you to suit your specific needs and pursue becoming a leading molecular diagnostic solution provider. GeneAll Biotechnology has been developed ...

Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity. Seegene has developed instruments for molecular diagnostics based on OEM partnership. In addition to that, Seegene has developed its own ...

EntroGen offers end-to-end molecular diagnostic solutions by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with proprietary software embedded for key decision ...

Azure Biotech Inc is a global biotechnology company that specializes in research & development, as well as the production and sales of diagnostic reagents, POCT analyzers and biological materials. Azure Biotech is also heavily involved in research ...

Archem Diagnostics; Our main focus is IVD reagents manufacturing and marketing. Having started its operations in 1998, Archem Diagnostics is one of the well-established biochemistry and hematology reagents manufacturer companies in Turkey. Our ...

We specialise in the development and production of innovative parameters and detection methods for laboratory diagnostics and medical research. Our focus is the development of immunological detection methods for unoccupied niches. The products from ...

RTI Group is a world-leading manufacturer of Medical X-ray testing and QA solutions. In 1982, we introduced the DIGI-X, marking a significant milestone as the first X-ray QA system for diagnostic radiology. In 1982, we introduced the first ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...

Virusight Diagnostic is a joint venture between Newsight Imaging and a ARC innovation center at Sheba Medical Center, the largest hospital in Israel and the Middle East, recognized by Newsweek magazine as one of the Top 10 Hospitals in the World. ...

We've manufactured over 8 million devices, three billion sensors, and developed the first FDA-cleared blood glucose meter/app for iPhone®. We've been featured by the New York Times and Fast Company, and work with some of the world's largest ...

Fortress Diagnostics is a multi award-winning global provider of in vitro diagnostics (IVDs). We develop, manufacture and support an extensive portfolio of clinical diagnostic tests from our ISO 13485:2016-accredited facility in the United Kingdom. ...

By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...

Ortho Clinical Diagnostics is a leading global provider of in vitro diagnostics. We have an established track record for providing high-quality products and services to the global clinical laboratory and immunohematology communities. Ortho Clinical ...

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been ...

The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, ...

We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...

Future Diagnostics is the obvious choice for in vitro diagnostic (IVD) assay development – for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market. With 20+ years of expert experience and 150 IVD ...

DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...